1)Kono T, Kanematsu T, Kitajima M:Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines:is it time yet? Surgery 146:837-840, 2009
2)André T, Boni C, Mounedji-Boudiaf L, et al:Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004
3)Park SB, Goldstein D, Lin CS, et al:Neuroprotection for oxaliplatin-induced neurotoxicity:what happened to objective assessment? J Clin Oncol 29:e553-554;author reply e555-556, 2011
4)Kaley TJ, Deangelis LM:Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol 145:3-14, 2009
5)Kono T:Kampo medicine daikenchuto―Its Exodus from the complementary and alternative medicines. Nihon Yakurigaku Zasshi 137:13-17, 2011
6)Yoshida T, Sawa T, Ishiguro T, et al:The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer. Support Care Cancer 17:315-320, 2009
7)Hidaka T, Shima T, Nagira K, et al:Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice. Eur J Pain 13:22-27, 2009
8)Kono T, Mamiya N, Chisato N, et al:Efficacy of Goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid Based Complement Alternat Med 2011 [doi:10.1093/ecam/nep 200]
9)Nishioka M, Shimada M, Kurita N, et al:The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int J Clin Oncol 16:322-327, 2011
10)Kono T, Mishima H, Shimada M, et al:Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy:a placebo-controlled double-blind randomized phase II study(the GONE Study). Jpn J Clin Oncol 39:847-849, 2009
11)McKemy DD:How cold is it? TRPM8 and TRPA1 in the molecular logic of cold sensation. Mol Pain 1:16, 2005
12)Kono T, Satomi M, Suno M, et al:Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation. Brain Behav 2:68-73, 2012
13)Hirotani Y, Doi A, Takahashi T, et al:Protective effects of the herbal medicine goshajinkigan in a rat model of non-alcoholic fatty liver disease. Biomed Res 33:373-376, 2012
14)Ushio S, Egashira N, Sada H, et al:Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Eur J Cancer 48:1407-1413, 2012